Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objectives of Cohort A Induction Study are: • To evaluate the efficacy of filgotinib as compared to placebo in establishing clinical remission by Patient Reported Outcomes (PRO2) at Week 10 • To evaluate the efficacy of filgotinib as compared to placebo in establishing endoscopic response at Week 10 The primary objectives of Cohort B Induction Study are: • To evaluate the efficacy of filgotinib as compared to placebo in establishing clinical remission by PRO2 at Week 10 • To evaluate the efficacy of filgotinib as compared to placebo in establishing endoscopic response at Week 10 The primary objectives of the Maintenance Study are: • To evaluate the efficacy of filgotinib as compared to placebo in establishing clinical remission by PRO2 at Week 58 • To evaluate the efficacy of filgotinib as compared to placebo in establishing endoscopic response at Week 58
Critère d'inclusion
- Moderately to Severely Active Crohn's Disease (CD)